Aurobindo Pharma Limited (AUROPHARMA) — Long-term Investment Intensity
Aurobindo Pharma Limited (AUROPHARMA) has a Long-term Investment Intensity of 1.7% as of September 2019. Long-term investments of Rs4.68 Billion represent 1.7% of total assets of Rs272.89 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check AUROPHARMA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Aurobindo Pharma Limited Long-term Investment Intensity (2014–2019)
This chart shows how Aurobindo Pharma Limited's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of September 2019, the intensity stands at 1.7%, reflecting long-term investments of Rs4.68 Billion against total assets of Rs272.89 Billion INR. Explore Aurobindo Pharma Limited cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Aurobindo Pharma Limited (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Aurobindo Pharma Limited from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Aurobindo Pharma Limited (AUROPHARMA) market capitalisation.
| Year | LT Investment Intensity | LT Investments (INR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.4% | Rs3.60 Billion | Rs264.54 Billion | ▼ -0.1 pp |
| 2018 | 1.5% | Rs3.12 Billion | Rs211.01 Billion | ▼ 0.0 pp |
| 2017 | 1.5% | Rs2.46 Billion | Rs162.49 Billion | ▲ +0.7 pp |
| 2016 | 0.8% | Rs1.23 Billion | Rs159.20 Billion | ▲ +0.8 pp |
| 2015 | 0.0% | Rs1.33 Million | Rs129.14 Billion | ▼ -0.2 pp |
| 2014 | 0.2% | Rs197.53 Million | Rs94.90 Billion | — |